These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7533952)

  • 1. Use of anticoagulants in patients with acute ischemic stroke.
    Counsell C; Sandercock P
    Stroke; 1995 Mar; 26(3):522-3. PubMed ID: 7533952
    [No Abstract]   [Full Text] [Related]  

  • 2. Targeted use of heparin, heparinoids, or low-molecular-weight heparin to improve outcome after acute ischaemic stroke: an individual patient data meta-analysis of randomised controlled trials.
    Whiteley WN; Adams HP; Bath PM; Berge E; Sandset PM; Dennis M; Murray GD; Wong KS; Sandercock PA
    Lancet Neurol; 2013 Jun; 12(6):539-45. PubMed ID: 23642343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Anticoagulation in stroke. Evidence-based and empirical indications].
    Walter U; Kloth A; Benecke R; Kunesch E
    Dtsch Med Wochenschr; 2003 Oct; 128(42):2200-5. PubMed ID: 14562219
    [No Abstract]   [Full Text] [Related]  

  • 4. Heparin and heparinoids in stroke.
    Sherman DG
    Neurology; 1998 Sep; 51(3 Suppl 3):S56-8. PubMed ID: 9744837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of venous thromboembolism: unfractionated heparin or low molecular weight heparins?
    Agnelli G
    Haematologica; 1995; 80(2 Suppl):78-83. PubMed ID: 7628776
    [No Abstract]   [Full Text] [Related]  

  • 6. Uses of heparin. Withhold in acute ischaemic stroke.
    Lindley RI; Sandercock PA
    BMJ; 1993 May; 306(6889):1410. PubMed ID: 8518621
    [No Abstract]   [Full Text] [Related]  

  • 7. Low-Molecular-Weight Heparin or Heparinoids vs. Unfractionated Heparin in Acute Ischemic Stroke.
    Newsom CT
    Am J Nurs; 2018 May; 118(5):61. PubMed ID: 29698282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticoagulant therapy in acute brain ischaemia.
    Eikelboom JW; Hart RG
    Lancet Neurol; 2013 Jun; 12(6):526-7. PubMed ID: 23642344
    [No Abstract]   [Full Text] [Related]  

  • 9. Low molecular weight heparin and unfractionated heparin in thrombosis prophylaxis after major surgical intervention: update of previous meta-analyses.
    Bergqvist D
    Br J Surg; 1998 Jun; 85(6):872. PubMed ID: 9667723
    [No Abstract]   [Full Text] [Related]  

  • 10. [Heparin during acute ischemic stroke. Present data and clinical situation].
    Daffertshofer M; Grips E; Dempfle CE; Hennerici M
    Nervenarzt; 2003 Apr; 74(4):307-19. PubMed ID: 12707700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Low molecular weight heparin: immediate therapy of stroke? A discussion of the study by Kay et al.: Low molecular weight heparin for treatment of acute ischemic stroke].
    Sporer B; Haberl RL
    Nervenarzt; 1996 Oct; 67(10):886-7. PubMed ID: 9036364
    [No Abstract]   [Full Text] [Related]  

  • 12. Low-molecular-weight heparins and heparinoids and their use in acute or progressing ischemic stroke.
    Gordon DL; Linhardt R; Adams HP
    Clin Neuropharmacol; 1990 Dec; 13(6):522-43. PubMed ID: 1703455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do we really need a better way to give heparin in acute cerebral ischemia?
    Hart RG; Easton JD
    Stroke; 2002 Mar; 33(3):659-60. PubMed ID: 11872882
    [No Abstract]   [Full Text] [Related]  

  • 14. Letters on management of ischemic stroke.
    Porat G
    Am Fam Physician; 2012 Sep; 86(6):492. PubMed ID: 23062038
    [No Abstract]   [Full Text] [Related]  

  • 15. [Standard heparin versus low-molecular-weight heparin].
    Lockner D
    Wien Med Wochenschr; 1999; 149(2-4):37-8. PubMed ID: 10378320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Deep venous thrombosis--treatment].
    Fries R; Böhm M
    Dtsch Med Wochenschr; 2003 May; 128(18):999-1002. PubMed ID: 12721879
    [No Abstract]   [Full Text] [Related]  

  • 17. Low molecular weight heparin: laboratory properties and clinical evaluation. A review.
    Hirsh J; Levine MN
    Eur J Surg Suppl; 1994; (571):9-22. PubMed ID: 7519092
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effects of the results of randomized trials on the tactics of management of patients with acute stroke].
    Warlow C
    Zh Nevrol Psikhiatr Im S S Korsakova; 1999; 99(2):47-50. PubMed ID: 10081136
    [No Abstract]   [Full Text] [Related]  

  • 19. Intravenous low-molecular-weight heparins compared with unfractionated heparin in percutaneous coronary intervention: quantitative review of randomized trials.
    Dumaine R; Borentain M; Bertel O; Bode C; Gallo R; White HD; Collet JP; Steinhubl SR; Montalescot G
    Arch Intern Med; 2007 Dec; 167(22):2423-30. PubMed ID: 18071163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The safety and usefulness of low molecular weight heparins and unfractionated heparins in patients with acute stroke.
    Kiphuth IC; Köhrmann M; Huttner HB; Schellinger PD
    Expert Opin Drug Saf; 2009 Sep; 8(5):585-97. PubMed ID: 19614560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.